Heparin-induced thrombocytopenia.

[1]  W. Hauck,et al.  Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. , 1997, Circulation.

[2]  J. Walenga,et al.  Anticoagulation with Novastan® (Argatroban) in Patients with Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis Syndrome , 1997, Seminars in thrombosis and hemostasis.

[3]  J. Kelton,et al.  A 14-year study of heparin-induced thrombocytopenia. , 1996, The American journal of medicine.

[4]  R. Aster,et al.  Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. , 1996, The Journal of laboratory and clinical medicine.

[5]  E. Antman.  Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. , 1996, Circulation.

[6]  H. Hemker,et al.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis". , 1996, The Journal of clinical investigation.

[7]  J. Amiral,et al.  Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopenia , 1996, British journal of haematology.

[8]  K. Lee,et al.  Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. , 1996, Circulation.

[9]  E. Topol,et al.  Potential value of platelet GPIIb/IIIa antagonist for treating heparin-induced thrombocytopenia (HIT) , 1996 .

[10]  M. Simoons.  A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. , 1996, The New England journal of medicine.

[11]  J. Kelton,et al.  Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination. , 1995, American journal of clinical pathology.

[12]  A. Jawad,et al.  Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. , 1995, American journal of clinical pathology.

[13]  R. Lindeman,et al.  Single amino acid mutation of FCγ receptor is associated with the development of heparin‐induced thrombocytopenia , 1995 .

[14]  J. Ferguson.  Meeting Highlights The 1995 European Society of Cardiology , 1995 .

[15]  R. Ramakrishna,et al.  Heparin‐induced thrombocytopenia: cross‐reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran) , 1995, British journal of haematology.

[16]  F. Schiele,et al.  Use of recombinant hirudin as antithrombotic treatment in patients with heparin‐induced thrombocytopenia , 1995, American journal of hematology.

[17]  J. Sixma,et al.  Comparing Subcutaneous Danaparoid with Intravenous Unfractionated Heparin for the Treatment of Venous Thromboembolism , 1995, Annals of Internal Medicine.

[18]  J. Hirsh,et al.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. , 1995, The New England journal of medicine.

[19]  M. Savage,et al.  Acute myocardial infarction during coronary angioplasty associated with heparin-induced thrombocytopenia. , 1995, Catheterization and cardiovascular diagnosis.

[20]  M. Horne,et al.  Importance of PF4 in heparin-induced thrombocytopenia: confirmation with gray platelets. , 1995, Blood.

[21]  J. Kelton,et al.  Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. , 1994, Blood.

[22]  V. Hach-Wunderle,et al.  Heparin-associated thrombosis despite normal platelet counts. , 1994, Lancet.

[23]  J. Kelton,et al.  Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. , 1994, Blood.

[24]  A. Greinacher,et al.  Heparin-Associated Thrombocytopenia: The Effects of Various Intravenous lgG Preparations on Antibody Mediated Platelet Activation - A Possible New Indication for High Dose i.v. IgG , 1994, Thrombosis and Haemostasis.

[25]  A. Greinacher,et al.  Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assay , 1994, Transfusion.

[26]  K. Lee,et al.  Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. , 1994, Journal of the American College of Cardiology.

[27]  V. Fuster,et al.  Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association. , 1994, Circulation.

[28]  J. Scott,et al.  Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. , 1994, The Journal of clinical investigation.

[29]  R. Edie,et al.  Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass. , 1993, Chest.

[30]  H. Magnani.  Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172) , 1993, Thrombosis and Haemostasis.

[31]  Y. Gruel,et al.  Further evidence that alpha-granule components such as platelet factor 4 are involved in platelet-IgG-heparin interactions during heparin-associated thrombocytopenia. , 1993, Thrombosis and haemostasis.

[32]  S. Nand.  Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis. , 1993 .

[33]  J. Kelton,et al.  Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies , 1993, British journal of haematology.

[34]  B. Chong,et al.  The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia , 1993, Thrombosis and Haemostasis.

[35]  B. P. Schmitt,et al.  Heparin-associated thrombocytopenia: a critical review and pooled analysis. , 1993, The American journal of the medical sciences.

[36]  B. Chong,et al.  Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. , 1993, Blood.

[37]  B. Chong,et al.  Heparin-induced thrombocytopenia , 1995, Australian and New Zealand journal of medicine.

[38]  K. Kario,et al.  TREATMENT OF HEPARIN‐INDUCED THROMBOCYTOPENIA BY USE OF ARGATROBAN, A SYNTHETIC THROMBIN INHIBITOR , 1992, British journal of haematology.

[39]  A. J. Block,et al.  Thrombocytopenia, cutaneous necrosis, and gangrene of the upper and lower extremities in a 35-year-old man. , 1992, Chest.

[40]  D. Pepper,et al.  Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4) , 1992, British journal of haematology.

[41]  J. Rasko,et al.  Acute adrenal insufficiency secondary to heparin–induced thrombocytopenia–thrombosis syndrome , 1992, The Medical journal of Australia.

[42]  J. Amiral,et al.  Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia , 1992, Thrombosis and Haemostasis.

[43]  D. Brushwood.  Hospital liable for allergic reaction to heparin used in injection flush. , 1992, American journal of hospital pharmacy.

[44]  A. Greinacher,et al.  Heparin‐associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan , 1992, British journal of haematology.

[45]  A. Greinacher,et al.  Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific , 1992, Thrombosis and Haemostasis.

[46]  D. Silver,et al.  Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition. , 1992, The Annals of thoracic surgery.

[47]  D. Meuleman.  Orgaran (Org 10172): its pharmacological profile in experimental models. , 1992, Haemostasis.

[48]  E. Favaloro,et al.  Heparin ‐ Induced Thrombocytopenia: Laboratory Investigation and Confirmation Of Diagnosis , 1992, Pathology.

[49]  A. Greinacher,et al.  A Rapid and Sensitive Test for Diagnosing Heparin-Associated Thrombocytopenia , 1991, Thrombosis and Haemostasis.

[50]  P. Lermusiaux,et al.  Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis , 1991, Annals of vascular surgery.

[51]  P. Brill-Edwards,et al.  Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. , 1991, Blood.

[52]  J. Riccio,et al.  Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis. , 1991, American journal of clinical pathology.

[53]  A. AbuRahma,et al.  Diagnostic and therapeutic strategies of white clot syndrome. , 1991, American journal of surgery.

[54]  Y. Gruel,et al.  Specific quantification of heparin-dependent antibodies for the diagnosis of heparin-associated thrombocytopenia using an enzyme-linked immunosorbent assay. , 1991, Thrombosis research.

[55]  Daksha P. Mehta,et al.  Heparin‐induced thrombocytopenia and thrombosis: Reversal with streptokinase a case report and review of literature , 1991, American journal of hematology.

[56]  C. Madden.  Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: The RISC Group Lancet 336: 827–830 Oct 1990 , 1991 .

[57]  M. Cupa,et al.  Adrenal hemorrhagic necrosis related to heparin-associated thrombocytopenia. , 1991, Critical care medicine.

[58]  P. Damas,et al.  Heparin-Induced Thrombocytopenia: A Case Report , 1990, Angiology.

[59]  Y. Gruel,et al.  Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis , 1990, The Lancet.

[60]  J. Anderson,et al.  Heparin-associated skin necrosis. , 1990, Postgraduate medical journal.

[61]  J. Bormanis,et al.  Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod. , 1990, Canadian journal of surgery. Journal canadien de chirurgie.

[62]  C. Fisher,et al.  Intraoperative management of patients with heparin-induced thrombocytopenia. , 1990, The Annals of thoracic surgery.

[63]  J. Kelton,et al.  Heparin and platelets. , 1990, Hematology/oncology clinics of North America.

[64]  K. Mulvey,et al.  Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin. , 1989, Annals of internal medicine.

[65]  R. J. Baird,et al.  Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis. , 1989, The Annals of thoracic surgery.

[66]  B. Chong,et al.  Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172 , 1989 .

[67]  D. Silver,et al.  Reexposure to heparin of patients with heparin-associated antibodies. , 1989, Journal of vascular surgery.

[68]  L. Eick,et al.  Lysed platelets shorten the activated coagulation time (ACT) of heparinized blood. , 1989, American journal of clinical pathology.

[69]  C. Fisher,et al.  Heparin-induced platelet activation: the role of thromboxane A2 synthesis and the extent of platelet granule release in two patients. , 1989, Journal of vascular surgery.

[70]  P. Théroux,et al.  Aspirin, heparin, or both to treat acute unstable angina. , 1988, The New England journal of medicine.

[71]  M. Sobel,et al.  Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism. , 1988, Journal of vascular surgery.

[72]  J. Kelton,et al.  Heparin-induced thrombocytopenia: laboratory studies. , 1988, Blood.

[73]  A. Elias,et al.  Treatment of serious heparin-induced thrombocytopenia by plasma exchange: report on 4 cases. , 1988, Thrombosis research.

[74]  J. A. Robinson,et al.  Plasmapheresis in the management of heparin‐associated thrombocytopenia with thrombosis , 1988, American journal of hematology.

[75]  A. Hartman,et al.  Phenomenon of heparin-induced thrombocytopenia associated with skin necrosis. , 1988, Journal of vascular surgery.

[76]  W. Bell,et al.  Heparin-associated thrombocytopenia and thrombosis. , 1988, The Journal of laboratory and clinical medicine.

[77]  A. Pradalier,et al.  [Right intraventricular thrombosis and thrombopenia due to heparin]. , 1988, Presse medicale.

[78]  D. Silver,et al.  Heparin-coated catheters and heparin-induced thrombocytopenia. , 1988, Journal of vascular surgery.

[79]  P. Stanton,et al.  White clot syndrome. , 1988, Southern medical journal.

[80]  W. Rizzoni,et al.  Heparin-induced thrombocytopenia and thromboembolism in the postoperative period. , 1988, Surgery.

[81]  D. Silver,et al.  The heparin-induced thrombocytopenia syndrome: an update. , 1987, Surgery.

[82]  J. C. Chang.  White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases. , 1987, Heart & lung : the journal of critical care.

[83]  A. Wycherley,et al.  The relative contributions of antithrombin III during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism. , 1987, Thrombosis research.

[84]  S. Tannenbaum,et al.  Immune endothelial-cell injury in heparin-associated thrombocytopenia. , 1987, The New England journal of medicine.

[85]  S. Adnot,et al.  Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia. , 1987, Haemostasis.

[86]  C. Fisher,et al.  Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management. , 1987, Journal of vascular surgery.

[87]  A. Wycherley,et al.  SAFETY AND EFFICACY OF WARFARIN STARTED EARLY AFTER SUBMASSIVE VENOUS THROMBOSIS OR PULMONARY EMBOLISM , 1986, The Lancet.

[88]  C. Greenberg,et al.  Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. , 1986, Journal of vascular surgery.

[89]  P. Castaldi,et al.  Heparin‐induced thrombocytopenia: further studies of the effects of heparin‐dependent antibodies on platelets , 1986, British journal of haematology.

[90]  C. Platell,et al.  Hypersensitivity reactions to heparin: delayed onset thrombocytopenia and necrotizing skin lesions. , 1986, The Australian and New Zealand journal of surgery.

[91]  J. Doty,et al.  Heparin-associated thrombocytopenia in the neurosurgical patient. , 1986, Neurosurgery.

[92]  M. D. Smith,et al.  Thrombolytic therapy in heparin-associated thrombocytopenia with thrombosis. , 1986, Clinical pharmacy.

[93]  P. Heeger,et al.  Heparin flushes and thrombocytopenia. , 1986, Annals of internal medicine.

[94]  J. Vender,et al.  Heparin-associated thrombocytopenia: alternative managements. , 1986, Anesthesia and analgesia.

[95]  J. Fiessinger,et al.  Heparin-induced thrombocytopenia and pentosan polysulfate: treatment with a low molecular weight heparin despite in vitro platelet aggregation. , 1986, Thrombosis and haemostasis.

[96]  J. Kelton,et al.  A diagnostic test for heparin-induced thrombocytopenia , 1986 .

[97]  Heparin-associated thrombocytopenia: antibody binding specificity to platelet antigens , 1985 .

[98]  J. Cohen,et al.  Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia. , 1985, Archives of internal medicine.

[99]  J. Isbister,et al.  Heparin-associated acute adrenal insufficiency. , 1985, Australian and New Zealand journal of medicine.

[100]  Y. Gruel,et al.  Treatment of Heparin-Associated Thrombocytopenia and Thrombosis with Low Molecular Weight Heparin (CY 216) , 1985, Seminars in thrombosis and hemostasis.

[101]  L. Weiss,et al.  Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG. , 1985, American journal of clinical pathology.

[102]  Howe Se,et al.  An enzyme-linked immunosorbent assay for the evaluation of thrombocytopenia induced by heparin. , 1985 .

[103]  D. Henry,et al.  Heparin‐induced thrombocytopenia: A prospective study , 1984, American journal of hematology.

[104]  S. Khuri,et al.  Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism. , 1984, The American journal of medicine.

[105]  R. Cipolle,et al.  Heparin‐induced thrombocytopenia in patients with cerebrovascular ischemic disease , 1984, Neurology.

[106]  G. Olinger,et al.  Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation. , 1984, The Journal of thoracic and cardiovascular surgery.

[107]  J. Kelton,et al.  Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. , 1984, The Journal of laboratory and clinical medicine.

[108]  D. J. King,et al.  Heparin-associated thrombocytopenia. , 1984, Annals of internal medicine.

[109]  A. Manoharan,et al.  Heparin‐induced skin reaction , 1984, The Medical journal of Australia.

[110]  J. Kelton,et al.  Studies on the frequency of heparin-associated thrombocytopenia. , 1984, Thrombosis research.

[111]  J. Gaux,et al.  Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase. , 1984, Thrombosis research.

[112]  M. Samama,et al.  Spontaneous platelet aggregation in heparin-treated patients. , 1984, Acta haematologica.

[113]  D. Rosengarten,et al.  Delayed‐onset heparin‐induced thrombocytopenia A potentially malignant syndrome , 1983, The Medical journal of Australia.

[114]  H. Bingham,et al.  Heparin-induced thrombocytopenia, thrombosis, and hemorrhage , 1980 .

[115]  B. Chong,et al.  HEPARIN-INDUCED THROMBOCYTOPENIA: ASSOCIATION OF THROMBOTIC COMPLICATIONS WITH HEPARIN-DEPENDENT IgG ANTIBODY THAT INDUCES THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION , 1982, The Lancet.

[116]  George Mendelson,et al.  Not “cured by a verdict” , 1982 .

[117]  F. Levine,et al.  Hyperlipoproteinemia as a significant risk factor for pulmonary embolism in patients undergoing coronary artery bypass grafting. , 1982, The Annals of thoracic surgery.

[118]  D. Silver,et al.  Heparin-induced thrombocytopenia with thrombosis and hemorrhage. , 1983, Archives of surgery.

[119]  W. Bell,et al.  Heparin-associated thrombocytopenia: a comparison of three heparin preparations. , 1980, The New England journal of medicine.

[120]  D. Deykin,et al.  Heparin‐induced thrombocytopenia and recurrent thromboembolism , 1980, American journal of hematology.

[121]  A. Gallus,et al.  Heparin-associated thrombocytopenia: case report and prospective study. , 1980, Australian and New Zealand journal of medicine.

[122]  D. Silver,et al.  Heparin-induced thrombocytopenia with thrombosis and hemorrhage. , 1981, Archives of surgery.

[123]  P. White,et al.  Thrombotic Complications of Heparin Therapy Including Six Cases of Heparin‐Induced Skin Necrosis , 1979, Annals of surgery.

[124]  J. Moake,et al.  Heparin‐induced thrombocytopenia: Association with a platelet aggregating factor and arterial thromboses , 1979, American journal of hematology.

[125]  V. Bernhard,et al.  White clot syndrome. Peripheral vascular complications of heparin therapy. , 1979, Archives of surgery.

[126]  R. Lerner,et al.  Heparin-induced thrombocytopenia. , 1978, Archives of internal medicine.

[127]  R. Patterson,et al.  Heparin immune thrombocytopenia: evidence for a heparin-platelet complex as the antigenic determinant. , 1978, The Journal of laboratory and clinical medicine.

[128]  R. Baird,et al.  Arterial thromboembolism in patients receiving systemic heparin therapy: a complication associated with heparin-induced thrombocytopenia. , 1977, The Journal of bone and joint surgery. American volume.

[129]  J. Byron.  CIMETIDINE AND BONE-MARROW TOXICITY , 1977, The Lancet.

[130]  R. B. Babcock,et al.  Heparin-induced immune thrombocytopenia. , 1976, The New England journal of medicine.

[131]  V. Arkoosh,et al.  NEONATAL RESUSCITATION , 2002 .

[132]  R. Rosenberg,et al.  Anticoagulant Action of Heparin , 1973, Nature.

[133]  D. Silver,et al.  Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. , 1973, Surgery, gynecology & obstetrics.

[134]  W. Bell,et al.  Therapeutic defibrination in the treatment of thrombotic disease. , 1968, Lancet.

[135]  S. Wessler,et al.  A Guide to Anticoagulant Therapy , 1961, Circulation.

[136]  R. Weismann,et al.  Arterial embolism occurring during systemic heparin therapy. , 1958, A.M.A. archives of surgery.